272 related articles for article (PubMed ID: 9178835)
1. Present status of purine analogs in the therapy of chronic lymphocytic leukemias.
Bergmann L
Leukemia; 1997 Apr; 11 Suppl 2():S29-34. PubMed ID: 9178835
[TBL] [Abstract][Full Text] [Related]
2. Purine analogs in the treatment of chronic lymphocytic leukemia.
Pott C; Hiddemann W
Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
[TBL] [Abstract][Full Text] [Related]
3. In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.
Morabito F; Stelitano C; Callea I; Filangeri M; Oliva B; Sculli G; Callea V; Nobile F; Brugiatelli M
Haematologica; 1996; 81(3):224-31. PubMed ID: 8767527
[TBL] [Abstract][Full Text] [Related]
4. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
5. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
Robak T; Kasznicki M
Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433
[TBL] [Abstract][Full Text] [Related]
6. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
Cheson BD; Vena DA; Barrett J; Freidlin B
J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside analogs in treatment of chronic lymphocytic leukemia.
Keating MJ; O'Brien S; Kantarjian H; Robertson LB; Koller C; Beran M; Estey E
Leuk Lymphoma; 1993; 10 Suppl():139-45. PubMed ID: 8097653
[TBL] [Abstract][Full Text] [Related]
8. Is there a place for 2-CDA in the treatment of B-CLL?
Mitterbauer M; Hilgenfeld E; Wilfing A; Jäger U; Knauf WU
Leukemia; 1997 Apr; 11 Suppl 2():S35-7. PubMed ID: 9178836
[TBL] [Abstract][Full Text] [Related]
9. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
10. Purine nucleoside analogues and combination therapies in B-cell chronic lymphocytic leukemia: dawn of a new era.
Nabhan C; Gartenhaus RB; Tallman MS
Leuk Res; 2004 May; 28(5):429-42. PubMed ID: 15068894
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of chronic lymphatic leukemia].
Adam Z; Vorlícek J; Hejlová N
Vnitr Lek; 1996 Aug; 42(8):573-8. PubMed ID: 8967031
[TBL] [Abstract][Full Text] [Related]
12. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in the management of chronic lymphocytic leukemia.
Robak T
Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
[TBL] [Abstract][Full Text] [Related]
14. The place of cladribine in the treatment of chronic lymphocytic leukemia: a 10-year experience in Poland.
Robak T
Ann Hematol; 2005 Feb; 84(2):63-70. PubMed ID: 15558283
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.
Stelitano C; Morabito F; Kropp MG; Callea V; Iuliano F; Oriana V; Levato D; Nobile F; Molica S; Brugiatelli M
Haematologica; 1999 Apr; 84(4):317-23. PubMed ID: 10190945
[TBL] [Abstract][Full Text] [Related]
16. Purine nucleoside analogues in the treatment of myleoid leukemias.
Robak T
Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309
[TBL] [Abstract][Full Text] [Related]
17. Cladribine in the treatment of chronic lymphocytic leukemia.
Robak T
Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
[TBL] [Abstract][Full Text] [Related]
18. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
Pott-Hoeck C; Hiddemann W
Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706
[TBL] [Abstract][Full Text] [Related]
19. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
Rucińska M; Machaczka M; Załuska A; Skotnicki AB
Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
[TBL] [Abstract][Full Text] [Related]
20. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
